Literature DB >> 24426822

Sleep disordered breathing in chronic spinal cord injury.

Abdulghani Sankari1, Amy Bascom1, Sowmini Oomman1, M Safwan Badr1.   

Abstract

STUDY
OBJECTIVES: Spinal cord injury (SCI) is associated with 2-5 times greater prevalence of sleep disordered breathing (SDB) than the general population. The contribution of SCI on sleep and breathing at different levels of injury using two scoring methods has not been assessed. The objectives of this study were to characterize the sleep disturbances in the SCI population and the associated physiological abnormalities using quantitative polysomnography and to determine the contribution of SCI level on the SDB mechanism.
METHODS: We studied 26 consecutive patients with SCI (8 females; age 42.5 ± 15.5 years; BMI 25.9 ± 4.9 kg/m2; 15 cervical and 11 thoracic levels) by spirometry, a battery of questionnaires and by attended polysomnography with flow and pharyngeal pressure measurements. Inclusion criteria for SCI: chronic SCI (> 6 months post injury), level T6 and above and not on mechanical ventilation. Ventilation, end-tidal CO2 (PETCO2), variability in minute ventilation (VI-CV) and upper airway resistance (RUA) were monitored during wakefulness and NREM sleep in all subjects. Each subject completed brief history and exam, Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), Berlin questionnaire (BQ) and fatigue severity scale (FSS). Sleep studies were scored twice, first using standard 2007 American Academy of Sleep Medicine (AASM) criteria and second using new 2012 recommended AASM criteria.
RESULTS: Mean PSQI was increased to 10.3 ± 3.7 in SCI patients and 92% had poor sleep quality. Mean ESS was increased 10.4 ± 4.4 in SCI patients and excessive daytime sleepiness (ESS ≥ 10) was present in 59% of the patients. Daytime fatigue (FSS > 20) was reported in 96% of SCI, while only 46% had high-risk score of SDB on BQ. Forced vital capacity (FVC) in SCI was reduced to 70.5% predicted in supine compared to 78.5% predicted in upright positions (p < 0.05). Likewise forced expiratory volume in first second (FEV1) was 64.9% predicted in supine compared to 74.7% predicted in upright positions (p < 0.05). Mean AHI in SCI patients was 29.3 ± 25.0 vs. 20.0 ± 22.8 events/h using the new and conventional AASM scoring criteria, respectively (p < 0.001). SCI patients had SDB (AHI > 5 events/h) in 77% of the cases using the new AASM scoring criteria compared to 65% using standard conventional criteria (p < 0.05). In cervical SCI, VI decreased from 7.2 ± 1.6 to 5.5 ± 1.3 L/min, whereas PETCO2 and VI-CV, increased during sleep compared to thoracic SCI.
CONCLUSION: The majority of SCI survivors have symptomatic SDB and poor sleep that may be missed if not carefully assessed. Decreased VI and increased PETCO2 during sleep in patients with cervical SCI relative to thoracic SCI suggests that sleep related hypoventilation may contribute to the pathogenesis SDB in patients with chronic cervical SCI.

Entities:  

Keywords:  Sleep; central apnea; spinal cord injury; tetraplegia

Mesh:

Year:  2014        PMID: 24426822      PMCID: PMC3869071          DOI: 10.5664/jcsm.3362

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  31 in total

1.  Using loop gain to assess ventilatory control in obstructive sleep apnea.

Authors:  M C Khoo
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

2.  Lung mechanics in individuals with spinal cord injury: effects of injury level and posture.

Authors:  A Baydur; R H Adkins; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  2001-02

3.  Delayed apnea in patients with mid- to lower cervical spinal cord injury.

Authors:  K Lu; T C Lee; C L Liang; H J Chen
Journal:  Spine (Phila Pa 1976)       Date:  2000-06-01       Impact factor: 3.468

4.  Complete absence of evening melatonin increase in tetraplegics.

Authors:  Rebecca J H M Verheggen; Helen Jones; Jean Nyakayiru; Andrew Thompson; Jan T Groothuis; Greg Atkinson; Maria T E Hopman; Dick H J Thijssen
Journal:  FASEB J       Date:  2012-04-02       Impact factor: 5.191

5.  Sleep apnea syndrome after spinal cord injury. Report of a case and literature review.

Authors:  A M Star; A L Osterman
Journal:  Spine (Phila Pa 1976)       Date:  1988-01       Impact factor: 3.468

6.  Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep.

Authors:  X S Zhou; S Shahabuddin; B R Zahn; M A Babcock; M S Badr
Journal:  J Appl Physiol (1985)       Date:  2000-07

7.  Sleep apnea syndrome in chronic spinal cord injury: associated factors and treatment.

Authors:  S P Burns; J W Little; J D Hussey; P Lyman; S Lakshminarayanan
Journal:  Arch Phys Med Rehabil       Date:  2000-10       Impact factor: 3.966

8.  Effect of episodic hypoxia on the susceptibility to hypocapnic central apnea during NREM sleep.

Authors:  Susmita Chowdhuri; Irina Shanidze; Lisa Pierchala; Daniel Belen; Jason H Mateika; M Safwan Badr
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

9.  A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway.

Authors:  E M Hagen; G E Eide; T Rekand; N E Gilhus; M Gronning
Journal:  Spinal Cord       Date:  2009-10-13       Impact factor: 2.772

10.  A sleep-induced apneic threshold and its consequences.

Authors:  J A Dempsey; J B Skatrud
Journal:  Am Rev Respir Dis       Date:  1986-06
View more
  39 in total

1.  Tetraplegia is associated with enhanced peripheral chemoreflex sensitivity and ventilatory long-term facilitation.

Authors:  Abdulghani Sankari; Amy T Bascom; Anas Riehani; M Safwan Badr
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Apnoea and hypopnoea scoring for people with spinal cord injury: new thresholds for sleep disordered breathing diagnosis and severity classification.

Authors:  Rachel Schembri; Marnie Graco; Jo Spong; Warren R Ruehland; Julie Tolson; Peter D Rochford; Brett Duce; Bronwyn Stevens; David J Berlowitz
Journal:  Spinal Cord       Date:  2019-01-09       Impact factor: 2.772

3.  Qualitative Experience of Sleep in Individuals With Spinal Cord Injury.

Authors:  Donald J Fogelberg; Natalie E Leland; Jeanine Blanchard; Timothy J Rich; Florence A Clark
Journal:  OTJR (Thorofare N J)       Date:  2017-02-14

4.  A retrospective review of sleep-disordered breathing, hypertenstion and cardiovascular diseases in spinal cord injury patients.

Authors:  A Sankari; J L Martin; M Badr
Journal:  Spinal Cord       Date:  2015-02-10       Impact factor: 2.772

Review 5.  Prevalence of sleep-disordered breathing in people with tetraplegia-a systematic review and meta-analysis.

Authors:  Marnie Graco; Luke McDonald; Sally E Green; Melinda L Jackson; David J Berlowitz
Journal:  Spinal Cord       Date:  2021-01-14       Impact factor: 2.772

6.  Tetraplegia is a risk factor for central sleep apnea.

Authors:  Abdulghani Sankari; Amy T Bascom; Susmita Chowdhuri; M Safwan Badr
Journal:  J Appl Physiol (1985)       Date:  2013-10-10

7.  Sleep-disordered breathing is associated with brain vascular reactivity in spinal cord injury.

Authors:  Jordan W Squair; Amanda H X Lee; Zoe K Sarafis; Geoff Coombs; Otto Barak; Jacquelyn J Cragg; Tanja Mijacika; Renata Pecotic; Andrei V Krassioukov; Zoran Dogas; Zeljko Dujic; Aaron A Phillips
Journal:  Neurology       Date:  2019-11-06       Impact factor: 9.910

8.  Sleep Complaints and Sleep Quality in Spinal Cord Injury: A Web-Based Survey.

Authors:  Shirin Shafazand; Kim D Anderson; Mark S Nash
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

9.  Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury.

Authors:  Ryan D Fortune; Raymond J Grill; Christine Beeton; Mark Tanner; Redwan Huq; David S Loose
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

10.  Diurnal blood pressure and urine production in acute spinal cord injury compared with controls.

Authors:  M Y Goh; M S Millard; E C K Wong; D J Brown; A G Frauman; C J O'Callaghan
Journal:  Spinal Cord       Date:  2016-06-28       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.